Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Mimedx (MDXG) Net Margin (2016 - 2024)

Mimedx (MDXG) has disclosed Net Margin for 14 consecutive years, with 8.01% as the latest value for Q4 2024.

  • Quarterly Net Margin fell 4362.0% to 8.01% in Q4 2024 from the year-ago period, while the trailing twelve-month figure was 1.89% through Sep 2025, down 2127.0% year-over-year, with the annual reading at 11.6% for FY2025, 43.0% down from the prior year.
  • Net Margin hit 8.01% in Q4 2024 for Mimedx, down from 9.37% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 51.63% in Q4 2023 to a low of 80.84% in Q3 2020.
  • Historically, Net Margin has averaged 4.57% across 5 years, with a median of 4.93% in 2021.
  • Biggest five-year swings in Net Margin: plummeted -9477bps in 2020 and later skyrocketed 7464bps in 2021.
  • Year by year, Net Margin stood at 26.35% in 2020, then skyrocketed by 90bps to 2.75% in 2021, then soared by 498bps to 10.94% in 2022, then soared by 372bps to 51.63% in 2023, then crashed by -84bps to 8.01% in 2024.
  • Business Quant data shows Net Margin for MDXG at 8.01% in Q4 2024, 9.37% in Q3 2024, and 20.21% in Q2 2024.